NCT01755234View on ClinicalTrials.gov

Propofol Versus Sevoflurane Recovery After Gynecological Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
SurgeryAnesthesia
Interventions
DRUG

Sevoflurane

Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube

DRUG

Propofol

Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60

Trial Locations (1)

60611

Prentice Women's Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01755234 - Propofol Versus Sevoflurane Recovery After Gynecological Surgery | Biotech Hunter | Biotech Hunter